CDK4 and melanoma: The first involvement of a CDK in a rare disease, familial melanoma, was reported more than 25 years ago, with the discovery of pathogenic mutations in the CDKN2 gene that codes for an inhibitor of CDK4, soon followed by the discovery of mutations in the CDK4 gene itself (reviewed in [5]).